NPS RADAR December 2007
Strontium ranelate: The PBS listing for the osteoporosis drug strontium ranelate has been extended to allow treatment of postmenopausal women without an existing fracture and a bone mineral density T-score ≤ -3.0 (primary prevention). The latest issue of NPS RADAR describes the place in therapy of strontium relative to other anti-resorptive agents.
It also contains information on:
- the listing of the anticonvulsant drug topiramate as an alternative treatment for migraine prevention, for adults unable to tolerate beta blockers or pizotifen
- updated safety information for the glitazones - rosiglitazone and pioglitazone.
See the complete reviews at www.npsradar.org.au